Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - HTG MOLECULAR DIAGNOSTICS, INC | d790335ds1a.htm |
| EX-4.7 - EX-4.7 - HTG MOLECULAR DIAGNOSTICS, INC | d790335dex47.htm |
| EX-4.6 - EX-4.6 - HTG MOLECULAR DIAGNOSTICS, INC | d790335dex46.htm |
| EX-4.1 - EX-4.1 - HTG MOLECULAR DIAGNOSTICS, INC | d790335dex41.htm |
| EX-10.7 - EX-10.7 - HTG MOLECULAR DIAGNOSTICS, INC | d790335dex107.htm |
| EX-10.8 - EX-10.8 - HTG MOLECULAR DIAGNOSTICS, INC | d790335dex108.htm |
| EX-10.1 - EX-10.1 - HTG MOLECULAR DIAGNOSTICS, INC | d790335dex101.htm |
| EX-10.9 - EX-10.9 - HTG MOLECULAR DIAGNOSTICS, INC | d790335dex109.htm |
| EX-10.18 - EX-10.18 - HTG MOLECULAR DIAGNOSTICS, INC | d790335dex1018.htm |
| EX-10.11 - EX-10.11 - HTG MOLECULAR DIAGNOSTICS, INC | d790335dex1011.htm |
| EX-10.10 - EX-10.10 - HTG MOLECULAR DIAGNOSTICS, INC | d790335dex1010.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
HTG Molecular Diagnostics, Inc.
Tucson, Arizona
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of our report dated February 25, 2015, relating to the financial statements of HTG Molecular Diagnostics, Inc., which is contained in that Prospectus. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO USA, LLP
Phoenix, Arizona
February 25, 2015